← Eichor
Condition: Friedreich Ataxia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Friedreich Ataxia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Phase 2 · 1 location(s) · Lexeo Therapeutics · NCT07721025A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Fried
Phase 3 · 34 location(s) · Biogen · NCT06953583Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.
NA · 1 location(s) · IRCCS Eugenio Medea · NCT07095062Friedreich Ataxia Nerve Ultrasund
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07508631Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia
Phase N/A · 6 location(s) · German Center for Neurodegenerative Diseases (DZNE) · NCT05943002Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia
NA · 1 location(s) · IRCCS Eugenio Medea · NCT06692296Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Phase N/A · 34 location(s) · Friedreich's Ataxia Research Alliance · NCT06016946A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who
Phase N/A · 14 location(s) · Biogen · NCT06623890A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia
Phase 1/Phase 2 · 3 location(s) · Design Therapeutics, Inc. · NCT06874010A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
Phase 1 · 3 location(s) · Solid Biosciences Inc. · NCT07180355Clinical Course Of Disease In Participants With FA-CM
Phase N/A · 19 location(s) · Lexeo Therapeutics · NCT06865482Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it Duri
Phase N/A · 1 location(s) · Biogen · NCT06628687Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Phase 1 · 1 location(s) · Weill Medical College of Cornell University · NCT05302271Efficacy of Omaveloxolone Treatment for Dysphagia in French Patients With Friedreich's Ataxia
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07013292Biomarkers in Friedreich's Ataxia
Phase N/A · 1 location(s) · University of Florida · NCT02497534Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT02316314An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
Phase 2 · 8 location(s) · Larimar Therapeutics, Inc. · NCT06447025
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.